High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria

PLoS One. 2022 Oct 13;17(10):e0275949. doi: 10.1371/journal.pone.0275949. eCollection 2022.

Abstract

Introduction: Racial disparities are known in the occurrence of kidney disease with excess risks found among people of African descent. Apolipoprotein L1 (APOL1) gene variants G1 and G2 are associated with kidney disease among HIV infected individuals of African descent in the USA as well as among black population in South Africa. We set out to investigate the prevalence of these high-risk variants and their effects on kidney disease among HIV infected patients in Northern Nigeria with hitherto limited information despite earlier reports of high population frequencies of these alleles from the Southern part of the country.

Methods: DNA samples obtained from the whole blood of 142 participants were genotyped for APOL1 G1 and G2 variants after initial baseline investigations including assessment of kidney function. Participants comprised 50 HIV positive patients with no evidence of kidney disease, 52 HIV negative individuals with no kidney disease and 40 HIV positive patients with chronic kidney disease (CKD) evidenced by persistent proteinuria and/or reduced eGFR, who also had a kidney biopsy. All the HIV positive patients were newly diagnosed and treatment naïve.

Results: The distribution of the APOL1 genotypes among the study participants revealed that 24.6% had a G1 risk allele and 19.0% a G2. The frequency of the High Risk Genotype (HRG) was 12.5% among those with CKD compared to 5.8% in the HIV negative group and zero in the HIV positive no CKD group. Having the HRG was associated with a higher odds for developing HIV Associated Nephropathy (HIVAN) (2 vs 0 risk alleles: OR 10.83, 95% CI 1.38-84.52; P = 0.023; 2 vs 0 or 1 risk alleles: OR 5.5, 95% CI 0.83-36.29; P = 0.07). The HRG was also associated with higher odds for Focal Segmental Glomerulosclerosis (FSGS) (2 vs 0 risk alleles: OR 13.0, 95% CI 2.06-81.91; P = 0.006 and 2 vs 0 or 1 risk alleles: OR 9.0, 95%CI 1.62-50.12; P = 0.01) when compared to the control group.

Conclusion: This study showed a high population frequency of the individual risk alleles of the APOL1 gene with higher frequencies noted among HIV positive patients with kidney disease. There is high association with the presence of kidney disease and especially FSGS and HIVAN among treatment naive HIV patients carrying two copies of the HRG.

MeSH terms

  • AIDS-Associated Nephropathy* / diagnosis
  • AIDS-Associated Nephropathy* / epidemiology
  • AIDS-Associated Nephropathy* / genetics
  • Apolipoprotein L1 / genetics
  • Apolipoproteins / genetics
  • Genetic Predisposition to Disease
  • Genotype
  • Glomerulosclerosis, Focal Segmental* / genetics
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • HIV Infections* / genetics
  • Humans
  • Lipoproteins, HDL / genetics
  • Nigeria / epidemiology
  • Renal Insufficiency, Chronic* / genetics
  • Risk Factors

Substances

  • APOL1 protein, human
  • Apolipoprotein L1
  • Apolipoproteins
  • Lipoproteins, HDL

Grants and funding

The Authors received no specific funding for this work